Circulating Cell Free DNA and DNA Integrity Index as Discriminating Tools between Breast Cancer and Benign Breast Disease

OBJECTIVES: Early diagnosis of cancer remains a great challenge in the field of laboratory medicine. We investigated the ability of ccf DNA and DNA integrity index (DNA II) in differentiating benign from malignant breast diseases. METHODS: Serum samples were collected from 50 patients with benign br...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhelaly, Rania, Effat, Narmen, Abd El-Fattah Hegazy, Mohamed, Abdelwahab, Khaled, Hamdy, Omar, Abo Hashem, Ekbal M, Elzehery, Rasha R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272613/
https://www.ncbi.nlm.nih.gov/pubmed/35225467
http://dx.doi.org/10.31557/APJCP.2022.23.2.545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272613/
https://www.ncbi.nlm.nih.gov/pubmed/35225467
http://dx.doi.org/10.31557/APJCP.2022.23.2.545

Ejemplares similares